Telehealth-aided outpatient management of acute heart failure in a specialist virtual ward compared with standard care.
Acute heart failure
Hospitalization
Mortality
Telehealth
Virtual ward
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
revised:
17
06
2024
received:
12
02
2024
accepted:
15
07
2024
medline:
14
8
2024
pubmed:
14
8
2024
entrez:
14
8
2024
Statut:
aheadofprint
Résumé
The aim of this propensity score matched cohort study was to assess the outcomes of telehealth-guided outpatient management of acute heart failure (HF) in our virtual ward (HFVW) compared with hospitalized acute HF patients. This cohort study (May 2022-October 2023) assessed outcomes of telehealth-guided outpatient acute HF management using bolus intravenous furosemide in a HF-specialist VW. Propensity score matching (PSM) was performed using logistic regression to adjust for potential differences in baseline patient characteristics between HFVW and standard care [Get With The Guidelines-HF score, clinical frailty score (CFS), Charlson co-morbidity index (CCI), NT-proBNP, and ejection fraction]. Clinical outcomes (re-hospitalizations and mortality) were compared at 1, 3, 6, and 12 months versus standard care-SC (acute HF patients managed without telehealth in 2021). Five hundred fifty-four HFVW ADHF patients (age 73.1 ± 10.9 years; 46% female) were compared with 404 ADHF patients (74.2 ± 11.8; P = 0.15 and 49% female) in the standard care-SC cohort. After propensity score matching for baseline patient characteristics, re-hospitalizations were significantly lower in the HFVW compared with SC (1 month-HFVW 8.6% vs. SC-21.5%, P < 0.001; 3 months-21% vs. 30%, P = 0.003; 6 months-28% vs 41%, P < 0.001 and 12 months-47% vs. 57%, P = 0.005) and mortality was also lower at 1 month (5% vs. 13.7%; P < 0.001), 3 months (9.5% vs. 15%; P = 0.001), 6 months (15% vs. 21%; P = 0.03), and 12 months (20% vs. 26%; P = 0.04). Multivariate logistic regression analysis showed that compared with standard care, HFVW management was associated with lower odds of readmission (1-month odds ratio (OR) = 0.3 [95% Confidence Interval CI 0.2-0.5], P < 0.0001; 3 month OR = 0.15 [0.1-0.3], P < 0.0001; 6-month OR = 0.35 [0.2-0.6], P = 0.0002; 12-month OR = 0.25 [0.15-0.4], P ≤ 0.001 and mortality (1-month OR = 0.26 [0.14-0.48], P < 0.0001; 3-month OR = 0.11 [0.04-0.27], P < 0.0001; 6-month OR = 0.35, [0.2; 0.61], P = 0.0002; 12-month OR = 0.6 [0.48; 0.73], P = 0.03. Higher GWTG-HF score independently predicted increased odds of re-hospitalization (1-month OR = 1.2 [1.1-1.3], P < 0.001; 3-month OR = 1.5 [1.37; 1.64], P < 0.0001; 6-month OR = 1.3 [1.2-1.4], P < 0.0001; 12-month OR = 1.1 [1.05-1.2], P = 0.03) as well as mortality (1-month OR = 1.21 [1.1-1.3], P < 0.0001; 3-month OR = 1.3 [1.2-1.4], P < 0.0001; 6-month OR = 1.2 [1.1-1.3], P < 0.0001; 12-month OR = 1.3 [1.1-1.7], P = 0.02). Similarly higher CFS also independently predicted increased odds of re-hospitalizations (1-month OR = 1.9 [1.5-2.4], P < 0.0001; 3-month OR = 1.8 [1.3-2.4], P = 0.0003; 6-month OR = 1.4 [1.1-1.8], P = 0.015; 12-month OR 1.9 [1.2-3], P = 0.01]) and mortality (1-month OR = 2.1 [1.6-2.8], P < 0.0001; 3-month OR = 1.8 [1.2-2.6], P = 0.006; 6-month OR = 2.34 [1.51-5.6], P = 0.0001; 12-month OR = 2.6 [1.6-7], P = 0.02). Increased daily step count while on HFVW independently predicted reduced odds of re-hospitalizations (1-month OR = 0.85[0.7-0.9], P = 0.005), 3-month OR = 0.95 [0.93-0.98], P = 0.003 and 1-month mortality (OR = 0.85 [0.7-0.95], P = 0.01), whereas CCI predicted adverse 12-month outcomes (OR = 1.2 [1.1-1.4], P = 0.03). Telehealth-guided specialist HFVW management for ADHF may offer a safe and efficacious alternative to hospitalization in suitable patients. Daily step count in HFVW can help predict risk of short-term adverse clinical outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHS Transformation Directorate (NHSX)
Informations de copyright
© 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1789‐1858. doi:10.1016/S0140‐6736(18)32279‐7
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007 Aug;154:260‐266. doi:10.1016/j.ahj.2007.01.041
Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJV, Granger CB, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007;116:1482‐1487. doi:10.1161/CIRCULATIONAHA.107.696906
Ahmed A, Allman RM, Fonarow GC, Love TE, Zannad F, Dell'italia LJ, et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: A propensity‐matched study. J Card Fail 2008;14:211‐218. doi:10.1016/j.cardfail.2007.12.001
Nieminen MS, Dickstein K, Fonseca C, Serrano JM, Parissis J, Fedele F, et al. The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol 2015;191:256‐264. doi:10.1016/j.ijcard.2015.04.235
British Heart Foundation. Heart failure: A blueprint for change [Internet]. British Heart Foundation. [cited 2024 Feb 11]. Available from: https://www.bhf.org.uk/what‐we‐do/policy‐and‐public‐affairs/transforming‐healthcare/heart‐failure‐report. Accessed 1 February 2024, doi:10.15288/jsad.24‐00037
Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz HS, et al. A systematic review of medical costs associated with heart failure in the USA (2014‐2020). Pharmacoeconomics 2020;38:1219‐1236. doi:10.1007/s40273‐020‐00952‐0
OECD. Health at a Glance: Europe 2022: State of Health in the EU Cycle [Internet]. Paris: Organisation for Economic Co‐operation and Development; 2022 [cited 2024 Feb 11]. Available from: https://www.oecd‐ilibrary.org/social‐issues‐migration‐health/health‐at‐a‐glance‐europe‐2022_507433b0‐en. Accessed 1 February 2024
Pak M, Hara M, Miura S, Furuya M, Tamaki M, Okada T, et al. Delirium is associated with high mortality in older adult patients with acute decompensated heart failure. BMC Geriatr 2020;20:524. doi:10.1186/s12877‐020‐01928‐7
van Berkel C, Almond P, Hughes C, Smith M, Horsfield D, Duckworth H. Retrospective observational study of the impact on emergency admission of telehealth at scale delivered in community care in Liverpool, UK. BMJ Open 2019;9:e028981. doi:10.1136/bmjopen‐2019‐028981
Darkins A, Ryan P, Kobb R, Foster L, Edmonson E, Wakefield B, et al. Care coordination/home telehealth: The systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions. Telemed J E Health 2008;14:1118‐1126. doi:10.1089/tmj.2008.0021
Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, et al. Effect of telehealth on use of secondary care and mortality: Findings from the whole system demonstrator cluster randomised trial. BMJ 2012 Jun;21:e3874. doi:10.1136/bmj.e3874
Hildebrandt H, Schulte T, Stunder B. Triple aim in Kinzigtal, Germany: Improving population health, integrating health care and reducing costs of care – lessons for the UK? J Integr Care 2012;20:205‐222. doi:10.1108/14769011211255249
Salisbury C, O'Cathain A, Thomas C, Edwards L, Gaunt D, Dixon P, et al. Telehealth for patients at high risk of cardiovascular disease: Pragmatic randomised controlled trial. BMJ 2016;353:i2647. doi:10.1136/bmj.i2647
Ko SQ, Kumar SK, Jacob J, Hooi BMY, Soo M, Nashi N, et al. Technology‐enabled HFVW for COVID management of the elderly and immunocompromised in Singapore: A descriptive cohort. BMC Infect Dis 2023;23:102. doi:10.1186/s12879‐023‐08040‐2
Norman G, Bennett P, Vardy ERLC. HFVWs: A rapid evidence synthesis and implications for the care of older people. Age Ageing 2023;52:afac319. doi:10.1093/ageing/afac319
Authors/Task Force Members, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4‐131. doi:10.1002/ejhf.2333
Essa H, Walker L, Mohee K, Oguguo C, Douglas H, Kahn M, et al. Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance. Open Heart 2022;9:e001979. doi:10.1136/openhrt‐2022‐001979
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373‐383. doi:10.1016/0021‐9681(87)90171‐8
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;173:489‐495. doi:10.1503/cmaj.050051
Royal College of Physicians. National Early Warning Score (NEWS) 2 [Internet]. RCP London. 2017 [cited 2024 Feb 11]. Available from: https://www.rcplondon.ac.uk/projects/outputs/national‐early‐warning‐score‐news‐2. Accessed 1 February 2024
Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, et al. A validated risk score for in‐hospital mortality in patients with heart failure from the American Heart Association Get With the Guidelines Program. Circ Cardiovasc Qual Outcomes 2010;3:25‐32. doi:10.1161/CIRCOUTCOMES.109.854877
Bo X, Zhang Y, Liu Y, Kharbuja N, Chen L. Performance of the heart failure risk scores in predicting 1 year mortality and short‐term readmission of patients. ESC Heart Fail. 2023;10:502‐517. doi:10.1002/ehf2.14208
Costa D, Aladio M, Girado CA, Pérez de la Hoz R, Sara BC. Frailty is independently associated with 1‐year mortality after hospitalization for acute heart failure. Int J Cardiol Heart Vasc 2018;21:103‐106. doi:10.1016/j.ijcha.2018.10.004
Salmon T, Essa H, Tajik B, Isanejad M, Akpan A, Sankaranarayanan R. The impact of frailty and comorbidities on heart failure outcomes. Card Fail Rev 2022;8:e07. doi:10.15420/cfr.2021.29
Newton PJ, Si S, Reid CM, Davidson PM, Hayward CS, Macdonald PS, et al. Survival after an acute heart failure admission. Twelve‐month outcomes from the NSW HF snapshot study. Heart Lung Circ 2020;29:1032‐1038. doi:10.1016/j.hlc.2019.09.004
Tan MKH, Wong JKL, Bakrania K, Abdullahi Y, Harling L, Casula R, et al. Can activity monitors predict outcomes in patients with heart failure? A systematic review. Eur Heart J Qual Care Clin Outcomes 2019;5:11‐21. doi:10.1093/ehjqcco/qcy038
Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190‐1195. doi:10.1056/NEJM199511023331806
Fonarow GC, Stevenson LW, Walden JA, Livingston NA, Steimle AE, Hamilton MA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725‐732. doi:10.1016/s0735‐1097(97)00208‐8
McAlister FA, Stewart S, Ferrua S, McMurray JJJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol 2004;44:810‐819. doi:10.1016/j.jacc.2004.05.055
Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010;363:2301‐2309. doi:10.1056/NEJMoa1010029
Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: The telemedical interventional monitoring in heart failure study. Circulation 2011;123:1873‐1880. doi:10.1161/CIRCULATIONAHA.111.018473
Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: The better effectiveness after transition ‐‐ heart failure (BEAT‐HF) randomized clinical trial. JAMA Intern Med 2016;176:310‐318. doi:10.1001/jamainternmed.2015.7712
Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM‐HF2): A randomised, controlled, parallel‐group, unmasked trial. Lancet 2018;392:1047‐1057. doi:10.1016/S0140‐6736(18)31880‐4
Takeda A, Martin N, Taylor RS, Taylor SJ. Disease management interventions for heart failure. Cochrane Database Syst Rev 2019;1:CD002752. doi:10.1002/14651858.CD002752.pub4
Ahmed FZ, Taylor JK, John AV, Khan MA, Zaidi AM, Mamas MA, et al. Ambulatory intravenous furosemide for decompensated heart failure: Safe, feasible, and effective. ESC Heart Fail 2021;8:3906‐3916. doi:10.1002/ehf2.13368
Greene SJ, Goto D, Wang D, Hilkert R, Lautsch D, Fonarow GC. Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States. Eur J Heart Fail 2022;24:2199‐2202. doi:10.1002/ejhf.2727
Lee C, Beleznai T, Hassan S, Rawat A, Douglas H, Kanagala P, et al. Ambulatory management of acute decompensation in heart failure. Br J Hosp Med (Lond) 2019;80:40‐45. doi:10.12968/hmed.2019.80.1.40
Lombardi C, Peveri G, Cani D, Latta F, Bonelli A, Tomasoni D, et al. In‐hospital and long‐term mortality for acute heart failure: Analysis at the time of admission to the emergency department. ESC Heart Fail. 2020;7:2650‐2661. doi:10.1002/ehf2.12847
Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ. ADHERE scientific advisory committee, study group, and investigators. Risk stratification for in‐hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 2005;293:572‐580. doi:10.1001/jama.293.5.572
Goyal P, Yum B, Navid P, Chen L, Kim DH, Roh J, et al. Frailty and post‐hospitalization outcomes in patients with heart failure with preserved ejection fraction. Am J Cardiol 2021;148:84‐93. doi:10.1016/j.amjcard.2021.02.019
NICOR. NICOR|Heart Failure (Heart Failure audit) [Internet]. [cited 2024 Feb 11]. Available from: https://www.nicor.org.uk/heart‐failure‐heart‐failure‐audit/. Accessed 1 February 2024, doi:10.15288/jsad.24‐00037
Essa H, Jackson C, Nyjo S, Kelly AM, Murphy N, Hartshorne‐Evans N, et al. Use of a self‐care and educational mobile app to improve outcomes of patients with acute decompensated heart failure during the COVID‐19 pandemic [Internet]. medRxiv; 2022 [cited 2023 Jul 1]. p. 2022.07.28.22270513. Available from: https://www.medrxiv.org/content/10.1101/2022.07.28.22270513v1. Accessed 1 February 2024
Krumholz HM. Post‐hospital syndrome‐‐An acquired, transient condition of generalized risk. N Engl J Med 2013;368:100‐102. doi:10.1056/NEJMp1212324
De Klein K, Valkenet K, Veenhof C. Perspectives of patients and health‐care professionals on physical activity of hospitalized patients. Physiother Theory Pract 2021;37:307‐314. doi:10.1080/09593985.2019.1626517
Ploux S, Strik M, Ramirez FD, Buliard S, Chauvel R, Dos Santos P, et al. Remote management of worsening heart failure to avoid hospitalization in a real‐world setting. ESC Heart Failure 2023;10:3637‐3645. doi:10.1002/ehf2.14553
Patel H, Shafazand M, Schaufelberger M, Ekman I. Reasons for seeking acute care in chronic heart failure. Eur J Heart Fail 2007;9:702‐708. doi:10.1016/j.ejheart.2006.11.002
Arsenault‐Lapierre G, Henein M, Gaid D, Le Berre M, Gore G, Vedel I. Hospital‐at‐home interventions vs in‐hospital stay for patients with chronic disease who present to the emergency department: A systematic review and meta‐analysis. JAMA Netw Open 2021;4:e2111568. doi:10.1001/jamanetworkopen.2021.11568